Rep. DeLauro Calls Hearing On FDA Drug Safety Highlighting Trasylol, Heparin
This article was originally published in The Pink Sheet Daily
Executive Summary
CBS News program “60 Minutes” is among the triggers for a “broad” hearing set for Feb. 27.
You may also be interested in...
Jerini’s Icatibant Falters in U.S., Wins In Europe
FDA rejects orphan drug for hereditary angioedema, paving way for rivals to gain an edge.
Jerini’s Icatibant Falters in U.S., Wins In Europe
FDA rejects orphan drug for hereditary angioedema, paving way for rivals to gain an edge.
U.S. FDA Inspected “Wrong” Heparin API Manufacturer – Compliance Official
Baxter heparin scare benefits American Pharmaceutical Partners, the other supplier of heparin to the U.S. market.